Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-06

Clinical Trial Update: CHIP/CCUS Natural History Protocol

View source ↗

Summary

An NHLBI-supported protocol to study the natural history of clonal hematopoiesis of indeterminate potential and clonal cytopenia of undetermined significance; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Clonal Hematopoiesis of Indeterminate Potential, Clonal Cytopenia of Undetermined Significance | Status: RECRUITING